FDA approves Roche’s Susvimo as the first and only continuous delivery treatment for the leading cause of diabetes-related blindness
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat ...
Medscape12d
Emerging Therapies for Diabetic Macular Edema
Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...
Healthline1mon
Helpful Diabetic Macular Edema Resources
Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood sugar levels can cause damage to the tiny blood vessels in the eyes. Globally, about 5.5% of people with diabetes ...
Nature11d
Cystoid Macular Edema Induced by Chemotherapy
Cystoid macular edema (CME) is a condition characterized ... The review highlighted various causes, including drug-induced cases, and emphasized the need for further investigation into treatment ...
WebMD4mon
Treatments for DME
Diabetic macular edema occurs when fluid leaks from blood ... Anti-VEGF injections block a protein that causes abnormal blood vessel growth. Your doctor injects medicine into your eye after ...
Pharmabiz14d
Health Canada authorizes Roche’s Vabysmo pre-filled syringe for three leading causes of vision loss
Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...